StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Immatics's operating cash flow for the twelve months ending Dec 31, 2024 was -€158.03M. For fiscal 2025 it was -€176.63M. The highest annual figure on record is €100.13M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€176.63M–
FY2024Dec 31, 2024-€158.03M-967.0%
FY2023Dec 31, 2023€18.23M-81.8%
FY2022Dec 31, 2022€100.13M–
FY2021Dec 31, 2021-€84.75M–
FY2020Dec 31, 2020-€80.70M-213.7%
FY2019Dec 31, 2019€70.97M+243.1%
FY2018Dec 31, 2018€20.68M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-€58.48M–
Q3 FY2024Sep 30, 2024-€33.73M–
Q2 FY2024Jun 30, 2024-€33.22M–
Q1 FY2024Mar 31, 2024-€32.61M–
Q2 FY2020Jun 30, 2020-€16.29M–
Q1 FY2020Mar 31, 2020-€11.45M–

More Immatics figures

See a number that looks wrong?